3D Signatures Inc. Announces Grant of Stock Options
June 27, 2017 07:30 ET
|
3D Signatures Inc.
TORONTO, June 27, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), announces that it has granted 10,000 incentive stock options (the...
3D Signatures Advances Hodgkin’s Lymphoma Test
June 08, 2017 07:00 ET
|
3D Signatures Inc.
TORONTO, June 08, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that the clinical trial component (the “Clinical...
3D Signatures Inc. Reports Third Quarter 2017 Financial Results
May 31, 2017 08:30 ET
|
3D Signatures Inc.
TORONTO, May 31, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), today reported operational and financial results for its fiscal third...
3D Signatures Announces Change to Its Board of Directors
May 05, 2017 11:00 ET
|
3D Signatures Inc.
TORONTO, May 05, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), announced today that Ferenc Somogyvari will be stepping down from the...
3D Signatures Receives First Prostate Cancer Blood Samples for Precise Clinical Trial
April 27, 2017 07:00 ET
|
3D Signatures Inc.
TORONTO, April 27, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that it has received the first batch of blood...
3D Signatures Announces Relocation to MaRS Discovery District in Toronto
April 18, 2017 08:30 ET
|
3D Signatures Inc.
WINNIPEG, Manitoba, April 18, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that the Company will relocate its...
3D Signatures Announces Appointment of Dr. Kevin Little as Chief Scientific Officer
April 11, 2017 09:15 ET
|
3D Signatures Inc.
WINNIPEG, Manitoba, April 11, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce the appointment of Dr. Kevin Little,...
3D Signatures Completes Assay Validation for Hodgkin’s Lymphoma Test
March 29, 2017 07:00 ET
|
3D Signatures Inc.
WINNIPEG, Manitoba, March 29, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that it has successfully completed...
3D Signatures’ TeloView™ Software Identifies and Stages Patients With Alzheimer’s Disease From a Cheek Swab
March 21, 2017 07:00 ET
|
3D Signatures Inc.
WINNIPEG, Manitoba, March 21, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce clinical study results which confirm...
3D Signatures Makes Final Patent Payment
March 14, 2017 08:00 ET
|
3D Signatures Inc.
WINNIPEG, Manitoba, March 14, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that it recently made the final...